CHGCY News and Press, Chugai Pharmaceuticals Co. Ltd. ADR From 10/23/20

Chugai Pharmaceutical Co Ltd (CHGCF) Q3 2020 Earnings Conference Call October 22, 2020, 05:00 ET Company Participants Toshiaki Itagaki - CFO Minoru Hirose - Department Manager, R&D Portfolio Management Dept. Shinji Hidaka - VP & Head, Marketing & Sales Division Conference Call Par...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. in conjunction with their 2020 Q3 earnings call. For further details see: Chugai Pharmaceutical Co., Ltd. 2020 Q3 - Results - Earnings Call Presentation

Chugai Pharmaceutical Co. Ltd (CHGCF) Half Year 2020 Earnings Conference Call July 27, 2020 4:00 AM ET Company Participants Tatsuro Kosaka – Chairman and Chief Executive Officer Toshiaki Itagaki – Chief Financial Officer Minoru Watanabe – Vice President, Head...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. in conjunction with their 2020 Q2 earnings Read more ...

TOKYO and BOSTON , July 21, 2020 /PRNewswire/ -- and July 22, 2020 - Chugai Pharmaceutical Co., Ltd.  ( TOKYO : 4519) and Biofourmis , a Boston -based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment of...

The value of proper clinical trials is that they give results that give confidence in the efficacy (or otherwise) of drugs. The UK has a complex major trial (RECOVERY) for testing drugs for treating COVID-19. Recent results from this trial were pivotal in the FDA deciding that hydroxychloro...

Unorthodox screeners for unorthodox times One of my favorite screeners on EquitiesLab.com is called after the names of three famous traders, the legendary one (Wyckoff) and two contemporary ones (O'Neill and Minervini). I created it on the basis of my readings of their books and my own in...

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2020 Results Conference Call April 23, 2020 05:00 AM ET Company Participants Toshiaki Itagaki - EVP and CFO Minoru Hirose - Head, R&D Portfolio Management Department Shinji Hidaka - General Manager, Marketing and Sales Conference ...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. in conjunction with their 2020 Q1 earnings Read more ...

Shares of Verastem Oncology   (NASDAQ: VSTM) , a biotechnology company developing new cancer drugs, are on the rise again after the company announced an upcoming conference call. Investors excited to hear what management will have to say about an investigator-initiated study (i.e., on...